GOAT'S RUE: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews

Overview

Goat's rue is a plant. The parts that grow above the ground are used to make medicine. Be careful not to confuse goat's rue (Galega officinalis) with rue (Ruta graveolens).

Goat's rue is used for diabetes, breast-feeding, and many other purposes, but there is no good scientific evidence to support its use.

How does it work ?

Goat's rue contains a chemical that may lower blood sugar in a test tube. But it is unclear if goat's rue has this effect when taken by people.

Uses & Effectiveness

Insufficient Evidence for

Breast-feeding. Some mothers have reported improvements in milk production after taking goat's rue with other vitamins and minerals, but this has not been studied in clinical trials.
Diabetes.
Digestive problems.
Other uses.

More evidence is needed to rate the effectiveness of goat's rue for these uses.

Side Effects

When taken by mouth: There isn't enough reliable information to know if goat's rue is safe or what the side effects might be. No harmful effects have been reported in humans, but fatal poisoning has occurred in grazing animals that ate large quantities of goat's rue.

Special Precautions and Warnings

Pregnancy and breast-feeding: There isn't enough reliable information to know if goat's rue is safe to use when pregnant or breast-feeding. Stay on the safe side and avoid use.

Bleeding conditions: Goat's rue might slow blood clotting and increase the risk of bleeding. In theory, goat's rue might make bleeding disorders worse.

Surgery: Goat's rue might affect blood sugar levels. There is concern that it might interfere with blood sugar control during and after surgery. Stop using goat's rue at least 2 weeks before a scheduled surgery.

Interactions

Moderate Interaction

Be cautious with this combination

Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs) interacts with GOAT'S RUE
Goat's rue might slow blood clotting. Taking goat's rue along with medications that also slow blood clotting might increase the chances of bruising and bleeding.

Some medications that slow blood clotting include aspirin, clopidogrel (Plavix), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, ticlopidine (Ticlid), warfarin (Coumadin), and others.

Dosing

The appropriate dose of goat's rue depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for goat's rue. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.

View References

REFERENCES:

Pond, S. M., Lewis-Driver, D. J., Williams, G. M., Green, A. C., and Stevenson, N. W. Gastric emptying in acute overdose: a prospective randomised controlled trial. Med J Aust 10-2-1995;163(7):345-349. View abstract.

Rashid, N. Medically unexplained myopathy due to ipecac abuse. Psychosomatics 2006;47(2):167-169. View abstract.

Rosenberg, N. L. and Ringel, S. P. Myopathy from surreptitious ipecac ingestion. West J.Med. 1986;145(3):386-388. View abstract.

Saincher, A., Sitar, D. S., and Tenenbein, M. Efficacy of ipecac during the first hour after drug ingestion in human volunteers. J.Toxicol.Clin.Toxicol. 1997;35(6):609-615. View abstract.

Scharman, E. J., Hutzler, J. M., Rosencrance, J. G., and Tracy, T. S. Single dose pharmacokinetics of syrup of ipecac. Ther.Drug Monit. 2000;22(5):566-573. View abstract.

Schiff, R. J., Wurzel, C. L., Brunson, S. C., Kasloff, I., Nussbaum, M. P., and Frank, S. D. Death due to chronic syrup of ipecac use in a patient with bulimia. Pediatrics 1986;78(3):412-416. View abstract.

Hadden, D. R. Goat's rue - French lilac - Italian fitch - Spanish sainfoin: gallega officinalis and metformin: the Edinburgh connection. J R.Coll.Physicians Edinb. 2005;35(3):258-260. View abstract.

Keeler, R. F., Baker, D. C., and Evans, J. O. Individual animal susceptibility and its relationship to induced adaptation or tolerance in sheep to Galega officinalis L. Vet.Hum.Toxicol. 1988;30(5):420-423. View abstract.

Keeler, R. F., Baker, D. C., and Panter, K. E. Concentration of galegine in Verbesina encelioides and Galega oficinalis and the toxic and pathologic effects induced by the plants. J Environ.Pathol.Toxicol.Oncol. 1992;11(2):11-17. View abstract.

Keeler, R. F., Johnson, A. E., Stuart, L. D., and Evans, J. O. Toxicosis from and possible adaptation to Galega officinalis in sheep and the relationship to Verbesina encelioides toxicosis. Vet.Hum.Toxicol. 1986;28(4):309-315. View abstract.

LAPYNINA, L. A. [ON FLAVONOID COMPOSITION OF GALEGA OFFICINALIS.]. Farm.Zh. 1965;20:57-62. View abstract.

Misbin, R. I. The phantom of lactic acidosis due to metformin in patients with diabetes. Diabetes Care 2004;27(7):1791-1793. View abstract.

Mooney, M. H., Fogarty, S., Stevenson, C., Gallagher, A. M., Palit, P., Hawley, S. A., Hardie, D. G., Coxon, G. D., Waigh, R. D., Tate, R. J., Harvey, A. L., and Furman, B. L. Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice. Br.J Pharmacol. 2008;153(8):1669-1677. View abstract.

Neef, H., Augustijns, P., Declercq, P., Declerck, P. J., and Laekeman, G. Inhibitory effects of Galega officinalis on glucose transport across monolayers of human intestinal epithelial cells. Pharmaceutical and Pharmacological Letters 1996;6:86-89.

Palit, P., Furman, B. L., and Gray, A. I. Novel weight-reducing activity of Galega officinalis in mice. J Pharm Pharmacol. 1999;51(11):1313-1319. View abstract.

Petricic, J. and Kalodera, Z. Galegin in the goat's rue herb: toxicity, antidiabetic activity and content determination. Acta Pharm Jugosl 1982;32:219-223.

PUFAHL, K. and SCHREIBER, K. [Isolation of a new guanidine derivative from goat's rue, Galega officinalis L.]. Experientia 7-15-1961;17:302-303. View abstract.

Pundarikakshudu, K., Patel, J. K., Bodar, M. S., and Deans, S. G. Anti-bacterial activity of Galega officinalis L. (Goat's Rue). J Ethnopharmacol. 2001;77(1):111-112. View abstract.

Rasekh, H. R., Nazari, P., Kamli-Nejad, M., and Hosseinzadeh, L. Acute and subchronic oral toxicity of Galega officinalis in rats. J Ethnopharmacol. 2-28-2008;116(1):21-26. View abstract.

Schafer, J. and Stein, M. [On the variability of substances contained in the goat's rue (Galega officinalis L.)]. Naturwissenschaften 1967;54(8):205. View abstract.

SCHREIBER, K., AURICH, O., and PUFAHL, K. [Isolation of peganine from goat's-rue, Galega officinalis L.]. Arch.Pharm 1962;295/67:271-275. View abstract.

Vuksan, V. and Sievenpiper, J. L. Herbal remedies in the management of diabetes: lessons learned from the study of ginseng. Nutr.Metab Cardiovasc.Dis. 2005;15(3):149-160. View abstract.

Atanasov AT. Effect of Galega officinalis L. extract on platelet aggregation in rats. J Herbs Spices Med Plants 1995;3:71-6.

Huxtable CR, Dorling RR, Colegate SM. Identification of galegine, an isoprenyl guanidine, as the toxic principle of Schoenus asperocarpus (poison sedge). Aust Vet J 1993;70:169-71. View abstract.

Lemus, I., Garcia, R., Delvillar, E., and Knop, G. Hypoglycaemic activity of four plants used in Chilean popular medicine. Phytother Res 1999;13(2):91-94. View abstract.

Neef H, Augustijns P, Declercq P, et al. Inhibitory effects of Galega officinalis on glucose transport across monolayers of human intestinal epithelial cells (Caco-2). Pharm Pharmacol Lett 1996;6:86-9.

Salatino S, Giacomelli L, Carnevali I, Giacomelli E. The role of natural galactagogues during breast feeding: focus on a Galega officinalis based food supplement. Minerva Pediatr. 2017 Dec;69(6):531-537. View abstract.

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2024 by Therapeutic Research Center, LLC. All Rights Reserved.